更多开发者作品
The Lancet Infectious Diseases
| 1. | [Newsdesk] Global Sanitation Summit 2024 | Manjulika Das | |
| 2. | [Clinical Picture] Strongyloides stercoralis hyperinfection syndrome | Lemna Jacob, Ayan Basu, Dipankar Paul, Yogiraj Ray, Nazneen Nahar Begam, Christy Varghese John | |
| 3. | [Newsdesk] Chad eliminates gambiense sleeping sickness | Alix Boisson-Walsh | |
| 4. | [Comment] Waiting is no longer an option for household contacts of people with drug-resistant tuberculosis | Jean Pannikottu, Anja Reuter, Elize Pietersen, Goodman Makhanda, Johnny Daniels, Busisiwe Beko, Ivy Apolisi, Jennifer Furin | |
| 5. | [Newsdesk] Setbacks and advances in the global HIV response | Ed Holt | |
| 6. | [Newsdesk] Infectious disease surveillance update | Aimee Ramgolam | |
| 7. | [Newsdesk] First report from the UK COVID-19 Inquiry | Talha Burki | |
| 8. | [Newsdesk] Research in brief | Priya Venkatesan | |
| 9. | [Obituary] Phyllis Dako-Gyeke | Sanjeet Bagcchi | |
| 10. | [Profile] Amanda Kvalsvig—from paediatrics to epidemiology | Tony Kirby | |
| 11. | [Newsdesk] Brazil to distribute paediatric antimalarial in Amazon | Sanjeet Bagcchi | |
| 12. | [Newsdesk] Limited progress towards immunisation targets in 2023 | Timothy Jesudason | |
| 13. | [Editorial] Oropouche fever, the mysterious threat | The Lancet Infectious Diseases | |
| 14. | [Correspondence] Emergence of an extensively drug-resistant Neisseria gonorrhoeae clone | Sebastiaan J van Hal, Norelle Sherry, Geoff Coombs, Shakeel Mowlaboccus, David M Whiley, Monica M Lahra | |
| 15. | [Media Watch] Anthony Fauci: a life on page | Bipin Adhikari, Lorenz Von Seidlein | |
| 16. | [Correspondence] Mortality of H5N1 human infections might be due to H5N1 virus pneumonia and could decrease by switching receptor | Guido Granata, Lone Simonsen, Nicola Petrosillo, Eskild Petersen | |
| 17. | [Correspondence] Recombination as an evolutionary driver of MERS-related coronavirus emergence | Jarel Elgin Tolentino, Spyros Lytras, Jumpei Ito, Edward C Holmes, Kei Sato | |
| 18. | [Correspondence] Alarming Plasmodium falciparum resistance to artemisinin-based combination therapy in Africa: the critical role of the partner drug | Anders Björkman, Pedro Gil, Michael Alifrangis | |
| 19. | [Correspondence] Artificial intelligence to transform public health in Africa | Collins Kipngetich Tanui, Nicaise Ndembi, Yenew Kebede, Sofonias Kifle Tessema | |
| 20. | [Correspondence] The potential role of the 4CMenB vaccine in combating gonorrhoea: the need for nuance in interpreting the DOXYVAC trial | Peter J White, Trystan Leng, Dariya Nikitin, Lilith K Whittles | |
| 21. | [Corrections] Correction to Lancet Infect Dis 2024; published online May 31. https://doi.org/10.1016/S1473-3099(24)00221-4 | | |
| 22. | [Corrections] Correction to Lancet Infect Dis 2022; 22: 265–73 | | |
| 23. | [Corrections] Correction to Lancet Infect Dis 2024; published online May 31. https://doi.org/10.1016/S1473-3099(24)00221-4 | | |
| 24. | [Comment] Vaccination hesistancy in Lyme borreliosis | Raymond J Dattwyler, Paul M Arnaboldi | |
| 25. | [Articles] Optimisation of dose level and vaccination schedule for the VLA15 Lyme borreliosis vaccine candidate among healthy adults: two randomised, observer-blind, placebo-controlled, multicentre, phase 2 studies | Nicole Bézay, Laura Wagner, Vera Kadlecek, Michaela Obersriebnig, Nina Wressnigg, Romana Hochreiter, Martina Schneider, Katrin Dubischar, Ulla Derhaschnig, Anton Klingler, Julian Larcher-Senn, Susanne Eder-Lingelbach, Wolfgang Bender | |
| 26. | [Articles] Long-term efficacy and immunogenicity of Ad26.RSV.preF–RSV preF protein vaccine (CYPRESS): a randomised, double-blind, placebo-controlled, phase 2b study | Ann R Falsey, Tessa Hosman, Arangassery Rosemary Bastian, Sjouke Vandenberghe, Eric K H Chan, Macaya Douoguih, Esther Heijnen, Christy A Comeaux, Benoit Callendret, CYPRESS investigators | |
| 27. | [Comment] The long-term efficacy of a respiratory syncytial virus vaccine for older adults | Charles J Sande | |
| 28. | [Comment] A bedaquiline, pretomanid, moxifloxacin, and pyrazinamide regimen for drug-susceptible and drug-resistant tuberculosis | Guofang Deng, Liang Fu | |
| 29. | [Articles] Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial | Muge Cevik, Lindsay C Thompson, Caryn Upton, Valéria Cavalcanti Rolla, Mookho Malahleha, Blandina Mmbaga, Nosipho Ngubane, Zamzurina Abu Bakar, Mohammed Rassool, Ebrahim Variava, Rodney Dawson, Suzanne Staples, Umesh Lalloo, Cheryl Louw, Francesca Conradie, Marika Eristavi, Anastasia Samoilova, Sergey N Skornyakov, Niyanda Elias Ntinginya, Frederick Haraka, George Praygod, Harriett Mayanja-Kizza, Janice Caoili, Vincent Balanag, Margareth Pretti Dalcolmo, Timothy McHugh, Robert Hunt, Priya Solanki, Anna Bateson, Angela M Crook, Stella Fabiane, Juliano Timm, Eugene Sun, Melvin Spigelman, Derek J Sloan, Stephen H Gillespie, SimpliciTB Consortium | |
| 30. | [Comment] Immune evasiveness of SARS-CoV-2 variants and vaccine selection | Malin Inghammar, Fredrik Kahn | |
| 31. | [Articles] Relative vaccine protection, disease severity, and symptoms associated with the SARS-CoV-2 omicron subvariant BA.2.86 and descendant JN.1 in Denmark: a nationwide observational study | Ida Rask Moustsen-Helms, Peter Bager, Tine Graakjær Larsen, Frederik Trier Møller, Lasse Skafte Vestergaard, Morten Rasmussen, Christian Holm Hansen, SSI-DMC Study Group | |
| 32. | [Articles] Field evaluation of validity and feasibility of Pan-Lassa rapid diagnostic test for Lassa fever in Abakaliki, Nigeria: a prospective diagnostic accuracy study | Jelte Elsinga, Temmy Sunyoto, Letizia di Stefano, Pier Francesco Giorgetti, Htet Aung Kyi, Chiara Burzio, Ximena Campos Moreno, Chiedozie K Ojide, Nnennaya Ajayi, Richard Ewah, Emeka O Ogah, Chioma Dan-Nwafor, Anthony Ahumibe, Chinwe Lucia Ochu, Adebola Olayinka, Sylvie Jonckheere, Pascale Chaillet, Michel van Herp | |
| 33. | [Comment] Rapid diagnostic tests for Lassa fever: what do we aim for? | Mirjam Groger, Michael Ramharter | |
| 34. | [Articles] Genotypic analysis of RTS,S/AS01E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5–17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trial | Michal Juraska, Angela M Early, Li Li, Stephen F Schaffner, Marc Lievens, Akanksha Khorgade, Brian Simpkins, Nima S Hejazi, David Benkeser, Qi Wang, Laina D Mercer, Samuel Adjei, Tsiri Agbenyega, Scott Anderson, Daniel Ansong, Dennis K Bii, Patrick B Y Buabeng, Sean English, Nicholas Fitzgerald, Jonna Grimsby, Simon K Kariuki, Kephas Otieno, François Roman, Aaron M Samuels, Nelli Westercamp, Christian F Ockenhouse, Opokua Ofori-Anyinam, Cynthia K Lee, Bronwyn L MacInnis, Dyann F Wirth, Peter B Gilbert, Daniel E Neafsey | |
| 35. | [Comment] Asymptomatic parasitemia and RTS,S vaccine efficacy | Nobuko Arisue, Nirianne Marie Q Palacpac | |
| 36. | [Comment] Identifying efficacious SARS-CoV-2 antivirals in a changing immune landscape | Leo G Visser | |
| 37. | [Articles] Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV) | Phrutsamon Wongnak, William H K Schilling, Podjanee Jittamala, Simon Boyd, Viravarn Luvira, Tanaya Siripoon, Thundon Ngamprasertchai, Elizabeth M Batty, Shivani Singh, Jindarat Kouhathong, Watcharee Pagornrat, Patpannee Khanthagan, Borimas Hanboonkunupakarn, Kittiyod Poovorawan, Mayfong Mayxay, Kesinee Chotivanich, Mallika Imwong, Sasithon Pukrittayakamee, Elizabeth A Ashley, Arjen M Dondorp, Nicholas P J Day, Mauro M Teixeira, Watcharapong Piyaphanee, Weerapong Phumratanaprapin, Nicholas J White, James A Watson, PLATCOV Collaborative Group | |
| 38. | [Articles] Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021 | GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators | |
| 39. | [Comment] Unveiling the viral aetiologies of lower respiratory infections | You Li, Xin Wang | |
| 40. | [Personal View] The emergence of artemisinin partial resistance in Africa: how do we respond? | Philip J Rosenthal, Victor Asua, Jeffrey A Bailey, Melissa D Conrad, Deus S Ishengoma, Moses R Kamya, Charlotte Rasmussen, Fitsum G Tadesse, Aline Uwimana, David A Fidock | |
| 41. | [Review] The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis—lessons from the South African experience | Kogieleum Naidoo, Rubeshan Perumal, Helen Cox, Barun Mathema, Marian Loveday, Nazir Ismail, Shaheed Vally Omar, Sophia B Georghiou, Amrita Daftary, Max O'Donnell, Norbert Ndjeka | |
| 42. | [Review] Use of a meningococcal group B vaccine (4CMenB) in populations at high risk of gonorrhoea in the UK | Shamez N Ladhani, Peter J White, Helen Campbell, Sema Mandal, Ray Borrow, Nick Andrews, Sunil Bhopal, John Saunders, Hamish Mohammed, Lana Drisdale-Gordon, Emma Callan, Katy Sinka, Kate Folkard, Helen Fifer, Mary E Ramsay | |
| 43. | [Personal View] Accelerating antibiotic access and stewardship: a new model to safeguard public health | Jennifer Cohn, Marc Mendelson, Souha S Kanj, Nusrat Shafiq, Icaro Boszczowski, Ramanan Laxminarayan | |
更新于 53 分钟前
近期历史最近 100 条记录
匿名用户只展示最新 100 条榜单历史，更多历史数据请登录后查看，支持时光机按天筛选
Sponsors
